From: Treatment outcomes of retinal vein occlusion in clinical practice in Nepal
CRVO | BRVO | p value | |
---|---|---|---|
Patients, n | 39 | 60 | |
Female, n (%) | 17 (44) | 35 (58) | |
Right Eye, n (%) | 26 (67) | 32 (53) | |
Hypertension, % | 51 | 65 | 0.25 |
Diabetes, % | 18 | 25 | 0.56 |
Hyperlipidaemia, % | 15 | 22 | 0.6 |
Smoking, % | 28 | 27 | 1 |
Alcohol, % | 10 | 10 | 1 |
Glaucoma, % | 0.1 | 0 | 0.15 |
Vision loss, days mean (SD) | 82 (78) | 114 (144) | 0.16 |
Age, years mean (SD) | 53 (17) | 58 (13) | 0.09 |
Baseline VA logMAR, mean (SD) | 1.13 (0.61) | 0.75 (0.42) | 0.001 |
VA ≤ 0.3 logMAR, % | 10 | 20 | 0.31 |
VA ≥ 1 logMAR, % | 59 | 37 | 0.04 |
Baseline IOP mm Hg, mean (SD) | 19 (11) | 16 (3) | 0.07 |
CST μm, mean (SD) | 519 (213) | 423 (151) | 0.02 |
Presence of Ischaemia | |||
Ischaemic, % | 18 | 20 | 1 |
NonIschaemic, % | 82 | 80 |